HOME >> BIOLOGY >> NEWS
Unified physics theory explains animals' running, flying and swimming

e. "It doesn't matter whether the animal has eight legs, four legs, two, even if it swims with no legs."

First conceived by Bejan and published in 1996, the constructal law arises from the basic principle that flow systems evolve so as to minimize imperfections -- energy wasted to friction or other forms of resistance -- such that the least amount of useful energy is lost.

The theory applies to virtually everything that moves, Bejan said. For example, his earlier work has examined how the law explains traffic flows, the cooling of small-scale electronics and river currents.

The researchers, funded by the National Science Foundation, report that the constructal law predicts universal relationships between animals' body mass and speed, as well as the frequency and force of the strides, beats or undulations that propel their bodies forward.

"Running, swimming and flying occur in vastly different physical environments and, likewise, involve quite different body mechanics," Bejan said of the new application of constructal law. "Nonetheless, there are strong convergences in certain functional characteristics of runners, swimmers and fliers."

For example, the stride frequency of running vertebrates bears the same relationship to the animals' mass as does the rate at which fish swim. Similarly, the velocity of runners conforms to the same principles as the speed of birds in flight.

The force generated by the muscular "motors" of runners, swimmers and fliers also conforms with surprisingly little variation to a universal value dependent only on muscle mass, Marden said. Why this relationship should be so had remained mysterious, he said.

In the absence of a unifying theory for such design features, biologists had looked to mechanical constraints for an answer, the researchers said. Many authors have suggested that effects of scale in locomotion stem from biomechanical safety factors: the need to avoid premature failu
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-660-8414
Duke University
30-Dec-2005


Page: 1 2 3 4 5

Related biology news :

1. Unraveling the physics of DNAs double helix
2. Pendulum love, science class gender gaps, musical mind mirrors, and unparticle physics
3. Manchester to spearhead 8.3 million particle physics project
4. Press conferences at the years largest physics meeting
5. Largest physics meeting of the year, in Denver
6. Protein folding physics, nanohandles, sunscreen for algae and classical quantum weirdness
7. Technique used commonly in physics finds application in neuroscience
8. What do Racquel Welch and quantum physics have in common?
9. APS physics tip sheet #62
10. Biggest physics meeting of the year
11. APS physics tip sheet #57

Post Your Comments:
(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
(Date:6/24/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Sharp has selected its industry-leading Natural ... its latest flagship smartphone device, the AQUOS ZETA ... shipments of its fingerprint ID sensor technology, this ... and leadership in the biometrics market through its ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
(Date:7/29/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... to progressing its ground-breaking technology platforms to Phase 1 ... the Company delivers the best value for shareholders. ... said the Company currently had an extensive program of ... and academic partnerships and initiatives, and he was working ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) ... Chief Financial Officer has resigned.  The Company has hired ... who retired in December 2014, as full time interim ... successor.     Andy Ashworth began his ... a smooth transition.  Andy was the Company,s CFO from ...
(Date:7/29/2015)... 29, 2015  AsureQuality and Ubiquitome have agreed ... applications in food and primary production sectors. The ... PCR device, the Freedom4. AsureQuality provides ... the supermarket shelf for producers, processors and Competent ... animal disease control and pest management and surveillance ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3
Cached News: